BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 37496090)

  • 1. Potency and safety analysis of hemp delta-9 products: the hemp vs. cannabis demarcation problem.
    Johnson L; Malone M; Paulson E; Swider J; Marelius D; Andersen S; Black D
    J Cannabis Res; 2023 Jul; 5(1):29. PubMed ID: 37496090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid Content and Label Accuracy of Hemp-Derived Topical Products Available Online and at National Retail Stores.
    Spindle TR; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; Winecker RE; Flegel RR; Bonn-Miller MO; Vandrey R
    JAMA Netw Open; 2022 Jul; 5(7):e2223019. PubMed ID: 35857320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using Transformer-Based Topic Modeling to Examine Discussions of Delta-8 Tetrahydrocannabinol: Content Analysis.
    Smith BP; Hoots B; DePadilla L; Roehler DR; Holland KM; Bowen DA; Sumner SA
    J Med Internet Res; 2023 Dec; 25():e49469. PubMed ID: 38127427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Cannabidiol, Δ
    ElSohly MA; Murphy TP; Khan I; Walker LW; Gul W
    Med Cannabis Cannabinoids; 2020 Aug; 3(1):1-13. PubMed ID: 34676337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid, Terpene, and Heavy Metal Analysis of 29 Over-the-Counter Commercial Veterinary Hemp Supplements.
    Wakshlag JJ; Cital S; Eaton SJ; Prussin R; Hudalla C
    Vet Med (Auckl); 2020; 11():45-55. PubMed ID: 32346530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Δ
    Babalonis S; Raup-Konsavage WM; Akpunonu PD; Balla A; Vrana KE
    Cannabis Cannabinoid Res; 2021 Oct; 6(5):362-365. PubMed ID: 34662224
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Yang Y; Lewis MM; Bello AM; Wasilewski E; Clarke HA; Kotra LP
    Cannabis Cannabinoid Res; 2017; 2(1):274-281. PubMed ID: 29098190
    [No Abstract]   [Full Text] [Related]  

  • 8. HPLC Method for Better Separation of THC Isomers to Ensure Safety and Compliance in the Hemp Market.
    Pittiglio MK; Ramirez GA; Tesfatsion TT; Ray KP; Cruces W
    ACS Omega; 2024 Jun; 9(23):25390-25394. PubMed ID: 38882159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ
    Wurz GT; Montoya E; DeGregorio MW
    J Cannabis Res; 2022 Jul; 4(1):36. PubMed ID: 35799289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance Testing of Hemp (
    Arsenault TL; Prapayotin-Riveros K; Ammirata MA; White JC; Dimkpa CO
    Plants (Basel); 2024 Feb; 13(4):. PubMed ID: 38498421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are adverse effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination?
    Lachenmeier DW; Habel S; Fischer B; Herbi F; Zerbe Y; Bock V; Rajcic de Rezende T; Walch SG; Sproll C
    F1000Res; 2019; 8():1394. PubMed ID: 32117565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The reintroduction of hemp in the USA: a content analysis of state and tribal hemp production plans.
    Falkner A; Kolodinsky J; Mark T; Snell W; Hill R; Luke A; Shepherd J; Lacasse H
    J Cannabis Res; 2023 Jun; 5(1):17. PubMed ID: 37280709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic and Chemical Diversity of Commercially Available High-CBD Industrial Hemp Accessions.
    Johnson MS; Wallace JG
    Front Genet; 2021; 12():682475. PubMed ID: 34306025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of cannabinoids in hemp nut products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: quality evaluation and a pilot human study.
    Chang CW; Tung CW; Tsai CC; Wu YT; Hsu MC
    Drug Test Anal; 2017 Jun; 9(6):888-897. PubMed ID: 27590030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays-and how this matters for the harm potential of seized drugs.
    Janssens LK; Van Uytfanghe K; Williams JB; Hering KW; Iula DM; Stove CP
    Arch Toxicol; 2024 May; ():. PubMed ID: 38735004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol (CBD) product contamination: Quantitative analysis of Δ
    Johnson E; Kilgore M; Babalonis S
    Drug Alcohol Depend; 2022 Aug; 237():109522. PubMed ID: 35690015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cross-reactivity of cannabinoid analogs (delta-8-THC, delta-10-THC and CBD), their metabolites and chiral carboxy HHC metabolites in urine of six commercially available homogeneous immunoassays.
    Wolf CE; Pokhai AA; Poklis JL; Williams GR
    J Anal Toxicol; 2023 Nov; 47(8):732-736. PubMed ID: 37602947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delta-8 tetrahydrocannabinol: a scoping review and commentary.
    LoParco CR; Rossheim ME; Walters ST; Zhou Z; Olsson S; Sussman SY
    Addiction; 2023 Jun; 118(6):1011-1028. PubMed ID: 36710464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute human exposure assessment to tetrahydrocannabinol (Δ
    ; Arcella D; Cascio C; Mackay K
    EFSA J; 2020 Jan; 18(1):e05953. PubMed ID: 32626501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Italian panorama of cannabis light preparation: Determination of cannabinoids by LC-UV.
    Dei Cas M; Casagni E; Saccardo A; Arnoldi S; Young C; Scotti S; Vieira de Manicor E; Gambaro V; Roda G
    Forensic Sci Int; 2020 Feb; 307():110113. PubMed ID: 31927249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.